Any pharmacy that contracts to compound a drug for parenteral therapy, pursuant to a prescription, for delivery to another pharmacy shall report that contractual arrangement to the board. That information shall be reported by the pharmacy performing the compounding services within 30 days of commencing that compounding.
(Repealed and added by Stats. 1996, Ch. 890, Sec. 3. Effective January 1, 1997.)